FDA Approves Maternal RSV Vaccine
August 21, 2023. Fenit Nirappil, Washington Post Federal regulators on Monday approved a maternal RSV vaccine administered during pregnancy to protect infants from severe illness. It’s the latest in a new arsenal of immunizations against the common respiratory virus that is the leading cause of hospitalization in young children and kills thousands of seniors annually. Read more.